– Data Presented During Oral Session at EASL 2023 Demonstrate Fazirsiran’s Promising Impact on Key…
– Data from two ongoing clinical trials in people living with chronic hepatitis B infection…
– Published data showed consistent and significant reductions in triglycerides, atherogenic lipoproteins and liver fat,…
– ENLIVEN results demonstrated that treatment with pegozafermin 30mg weekly and 44mg every-two-week doses resulted…
Daix (France), Long Island City (New York, United States), June 24, 2023 – Inventiva (Euronext…
Luxembourg, Jun 24, 2023 – (ACN Newswire) – SourceLess, a groundbreaking technology company, announces its…
Eight weeks after completing treatment with BMF-219, patients with type 2 diabetes (T2D) showed an…
– Once-weekly administration of CT-388 delivers clinically meaningful weight loss and metabolic control with a…
The proxy voting deadline for XORTX shareholders to vote their proxies is 10:00 a.m. (Calgary…
First late-stage study will be a Phase 2b dose optimization study, with extension to run…
EMERYVILLE, Calif., June 23, 2023 (GLOBE NEWSWIRE) — XOMA Corporation (NASDAQ: XOMA), the biotech royalty…
WINNIPEG, Manitoba, June 23, 2023 (GLOBE NEWSWIRE) — Kane Biotech Inc. (TSX-V:KNE; OTCQB:KNBIF), (the “Company”…
Press Release No. 5 / 2023 Data shows nearly 19% weight loss in people with…
TORONTO, June 23, 2023 (GLOBE NEWSWIRE) — Biosenta Inc. (the “Company” or “Biosenta”) (CSE: ZRO)…
LOS ANGELES, June 23, 2023 (GLOBE NEWSWIRE) — (NASDAQ: ENOB). Enochian BioSciences Inc., a company…
ERYTECH announces the approval of the merger with Pherecydes and reports the results of…
AC Immune Holds Annual General Meeting of Shareholders Shareholders approved all resolutions as proposed by…
TORONTO, June 23, 2023 (GLOBE NEWSWIRE) — Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or…
Plymouth Meeting, Pa., June 23, 2023 (GLOBE NEWSWIRE) — INOVIO (NASDAQ:INO) has released the following…
ARLINGTON, Mass., June 23, 2023 (GLOBE NEWSWIRE) — Kala Pharmaceuticals, Inc. (NASDAQ:KALA), today announced that…